Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis

George C Bao1, Jian-Guang Wang, Ambrose Jong

  • 1Division of Hematology/Oncology, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles, CA 90027, USA.

FEBS Letters
|June 13, 2006
PubMed

Insights

Retinoic acid (RA) induces lymphoma cell death by upregulating p21, a cyclin-dependent kinase (CDK) inhibitor. This p21 upregulation diverts CDK2 from proliferation to apoptosis, revealing a novel RA signaling pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cip/Kip protein p21 acts as a cyclin-dependent kinase (CDK) inhibitor.
  • Retinoic acid receptor alpha (RARalpha) directly transactivates p21 upon retinoic acid (RA) binding.
  • The function of RA-induced p21 upregulation in lymphoma remains unclear.

Purpose of the Study:

  • To investigate the role of p21 upregulation by RA in human pre-B lymphoma Nalm6 cells.
  • To elucidate the mechanism by which RA inhibits lymphoma cell proliferation.

Main Methods:

  • Treatment of Nalm6 cells with RA.
  • Analysis of cell death, apoptosis markers (caspase-3 activation), and protein complex formation (p21 with cyclin E/CDK2).
  • Assessment of cyclin E and CDK2 protein levels.

Main Results:

  • RA induced proliferation inhibition in Nalm6 cells, characterized by massive apoptosis.
  • RA-induced p21 upregulation preceded and accompanied caspase-3 activation.
  • p21 formed complexes with cyclin E/CDK2, while cyclin E and CDK2 levels remained constant.
  • CDK2's function was diverted from proliferation to apoptosis promotion.

Conclusions:

  • RA induces apoptosis in lymphoma cells via p21 upregulation.
  • p21/cyclin E/CDK2 complex formation is a key event in RA-induced apoptosis.
  • A novel RA signaling pathway exists where p21 diverts CDK2 function to promote apoptosis, rather than proliferation.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...